Eligibility Matcher
Select your organization type below to see only the grants you qualify for — sorted by soonest deadline.
Native American tribal organizations (other)Nonprofits having 501(c)(3) statusNonprofits without 501(c)(3) statusPrivate institutions of higher educationIndividualsFor-profit organizationsSmall businessesOthersUnrestrictedState governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic/State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities
384 grants for For-profit organizations
Sorted by deadline (soonest first)
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
HHS-NIH11 · RFA-OD-27-008
Closes Dec 2, 2026
NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
HHS-NIH11 · RFA-OD-24-011
Closes Dec 4, 2026
Air Force Fiscal Year 2027 Young Investigator Program (YIP)
DOD-AFOSR · FA955026S0003
Closes Dec 4, 2026
MPPEP Phase 3 Invasive Wild-Caught Catfish
USDA-RBCS · RD-RBS-26-03-MPPEP
Closes Dec 7, 2026
Silicon Carbide Cladding Lead Test Rod Development-Phase 1
DOE-ID · DE-FOA-0003577
Closes Dec 7, 2026
Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
HHS-CDC-HHSCDCERA · RFA-OH-26-001
Closes Dec 8, 2026
Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
HHS-CDC-HHSCDCERA · RFA-OH-26-015
Closes Dec 8, 2026
Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)
HHS-NIH11 · RFA-HG-27-010
Closes Dec 14, 2026
Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)
HHS-NIH11 · RFA-HG-27-007
Closes Dec 14, 2026
Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)
HHS-NIH11 · RFA-HG-27-009
Closes Dec 14, 2026
IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)
HHS-NIH11 · RFA-HG-27-008
Closes Dec 14, 2026
SEFSC Bluefin Tuna Research Program
DOC-DOCNOAAERA · NOAA-NMFS-SE-2027-33642
Closes Dec 31, 2026
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-221
Closes Jan 7, 2027
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
HHS-NIH11 · PAR-25-098
Closes Jan 7, 2027
Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
HHS-NIH11 · PAR-25-378
Closes Jan 7, 2027
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-379
Closes Jan 7, 2027
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-256
Closes Jan 7, 2027
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
HHS-NIH11 · PAR-25-159
Closes Jan 7, 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-069
Closes Jan 7, 2027
Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-310
Closes Jan 7, 2027
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-167
Closes Jan 7, 2027
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-081
Closes Jan 7, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
HHS-NIH11 · PAR-25-025
Closes Jan 7, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
HHS-NIH11 · PAR-25-026
Closes Jan 7, 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-070
Closes Jan 7, 2027